C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of e...
Saved in:
Main Authors: | Dusica Vasic, Daniel Walcher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/858692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proinflammatory Effects of C-Peptide in Different Tissues
by: Dusica Vasic, et al.
Published: (2012-01-01) -
Galectin-3 Is a Potential Mediator for Atherosclerosis
by: Ziyu Gao, et al.
Published: (2020-01-01) -
A Peptide Analogue of Selectin Ligands Attenuated Atherosclerosis by Inhibiting Monocyte Activation
by: Zhishuai Ye, et al.
Published: (2019-01-01) -
Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis
by: Simone Filardo, et al.
Published: (2015-01-01) -
The Impact of C-Peptide and Diabetes Mellitus on Coronary Ectasia and Effect of Coronary Ectasia and C-Peptide on Long-Term Outcomes: A Retrospective Cohort Study
by: Kenan Toprak, et al.
Published: (2022-01-01)